Recent KNSA News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/23/2024 09:02:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 12:53:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 12:52:41 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 12:51:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 12:42:54 AM
- Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference • GlobeNewswire Inc. • 08/28/2024 08:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/23/2024 08:39:43 PM
- Form 15-15D/A - Suspension of duty to report [Section 13 and 15(d)]: [Amend] • Edgar (US Regulatory) • 07/23/2024 08:38:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/23/2024 08:38:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 11:54:56 AM
- Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution • GlobeNewswire Inc. • 07/23/2024 11:30:00 AM
- Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024 • GlobeNewswire Inc. • 07/16/2024 08:01:00 PM
- Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease • GlobeNewswire Inc. • 07/09/2024 12:00:00 PM
- Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis • GlobeNewswire Inc. • 06/24/2024 12:00:00 PM
- Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative • GlobeNewswire Inc. • 06/17/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:27:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:27:43 PM
- Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 08:01:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/29/2024 09:19:51 PM
- Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference • GlobeNewswire Inc. • 05/07/2024 08:01:00 PM
- Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution • GlobeNewswire Inc. • 04/23/2024 11:30:00 AM
- Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024 • GlobeNewswire Inc. • 04/16/2024 08:01:00 PM
- Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart • GlobeNewswire Inc. • 04/02/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:34:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:31:55 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM